Bizarre Patents
Cloaking System Using Optoelectronically Controlled Camouflage
A Cloaking System designed to operate in the visible light spectrum, utilizes optoelectronics and/or photonic components to conceal an object within it.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7364758 | Pharmaceutical use of Graptopetalum and related plants The present invention relates to compositions comprising Graptopetalum and uses thereof Graptopetalum can protect animals from liver diseases and medical conditions, such as inflammation, steatosis, and fibrosis. In particular, Graptopetalum inh... | 04/29/2008 |
| 7345066 | Use of thiazole derivatives for preparing a medicine for protecting mitochondria The invention concerns compounds of general formula (I), wherein: A represents one of the radicals in which R5 represents independently a hydrogen atom, or alkyl; R6, R7 and R8 independently represent a hydrogen atom, alky... | 03/18/2008 |
| 7078045 | Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis A pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis, which comprises 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and dimethyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate (DDB) as ma... | 07/18/2006 |
| 6863904 | Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects The present invention relates to compositions without added iron and methods for prophylactic nutritional supplementation and therapeutic nutritional supplementation. Specifically, the method involves administering to an individual a composition comprising carotenoi... | 03/08/2005 |
| 6686332 | Method of treating depressed reticuloendothelial system function The present invention provides methods of treating adverse physiological effects associated with depressed reticuloendothelial system function comprising administering to a subject suffering from depressed reticuloendothelial system function an effective ... | 02/03/2004 |
| 6596745 | Method for treating fibrotic diseases with azolium chroman compounds Provided is a method of treating or ameliorating hypertension in an animal comprising administering an effective amount of a compound of formula I: ##STR1##... | 07/22/2003 |
| 6583127 | Use of etherlysophospholipids as antiinflammatory agents The present invention relates to the use of a series of etherlysophospholipids (ELPs) for the preparation of a medicament for the treatment of an inflammatory disease without causing adverse gastrointestinal side effects and/or without inhibition of phosp... | 06/24/2003 |
| 6316502 | Therapeutic methods employing disulfide derivatives of dithiocarbonates and compositions useful therefor The present invention provides a novel dithiocarbamamte disulfide dimer useful in various therapeutic treatments, either alone or in combination with other active agents. In one method, the disulfide derivative of a dithiocarbamate is coadministered with ... | 11/13/2001 |
| 5900434 | Method for inhibiting the production of interleukin-1 or tumor necrosis factor- by administering acanthoic acid Process for the preparation of (-)-pimara-9(11),15-diene-19-oic acid(acanthoic acid) and pharmaceutical compositions comprising acanthoic acid useful for the treatment of diseases caused by an excessive production of interleukin-1 or tumor necrosis factor... | 05/04/1999 |
| 5880101 | Clinical uses of polyene macrolides The present invention relates to the use of at least one polyene macrolide for the preparation of pharmaceutical compositions for the treatment of diseases that are associated with an impaired energy turnover. Particularly, the present inventions allows t... | 03/09/1999 |
| 5716632 | Compositions and methods for reparation and prevention of fibrotic lesions In a preferred embodiment, drugs having pharmacological properties which are useful in the medicinal therapy of fibrotic disease for the reparation and prevention of fibrotic lesional tissues, such drugs including as active ingredient(s) one or more N-sub... | 02/10/1998 |
| 5710132 | Use of bovine colostral milk as a preparation for the protection of the liver The invention relates to the use of colostral milk or colostral milk preparations from the cow, or fractions containing immunoglobulin prepared therefrom, as a liver protective preparation for the prevention and treatment of liver function disturbances in... | 01/20/1998 |
| 5703048 | Protection against liver damage by HGF The present invention provides methods for preventing occurrence or progression of liver damage using hepatocyte growth factor. In the methods, a preventatively effective amount of the hepatocyte growth factor is administered to the patient. The hepatocyt... | 12/30/1997 |
| 5660822 | Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use The present invention concerns a method for treating fibrotic conditions by administration of an effective amount of an antifibrotic agent. The antifibrotic agent is preferably a proline analog, such as cis-4-hydroxy-L-proline (cHyp). The antifibrotic age... | 08/26/1997 |
| 5529778 | Ayurvedic composition for the prophylaxis and treatment of AIDS, flu, TB and other immuno-deficiencies and the process for preparing the same An ayurvedic composition for prophylaxis and treatment of AIDS, flu, TB, and other immuno-deficiency conditions, and for liver diseases such as hepatitis and sclerosis, includes prescribed doses of extracts or isolates of two multi-component drugs in sele... | 06/25/1996 |
| 5518729 | Compositions and methods for reparation and prevention of fibrotic lesions In a preferred embodiment, drugs having pharmacological properties which are useful in the medicinal therapy of fibrotic disease for the reparation and prevention of fibrotic lesional tissues, such drugs including as the active ingredient one or more N-su... | 05/21/1996 |
| 5500409 | Method for inhibiting collagen synthesis by keloid fibroblasts A composition for the treatment of skin fibrotic and other cirrhotic diseases comprising an endothelial cell growth factor, either alone or in combination with heparin or a heparin-like compound is provided. Methods for the treatment of skin fibrotic and ... | 03/19/1996 |
| 5492891 | Method for treatment of patients with chronic liver disease Patients with chronic liver disease and consequently very low concentrations of IGF-1 in the blood, in spite of increased GH concentrations, are treated with periodically injections of hGH for a period both parameters being individually adjusted for the p... | 02/20/1996 |
| 5360613 | Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol Patients with elevated blood levels of low-density lipoprotein (LDL) and total cholesterol are treated by administering ଲ-hydroxy-ଲ-methylbutyric acid (HMB) to reduce the patient's blood level of LDL and total cholesterol. HMB can be safely ad... | 11/01/1994 |
| 5320846 | Method and composition for testing patients with metabolic depleting diseases A method of treating patients with clinical disorder involving splanchnic disorders such as liver or gut dysfunction, the dysfunction being characterized by depletion of metabolic energy sources. The treatment involves the step of administering an effecti... | 06/14/1994 |
| 5310562 | Composition and method for reparation and prevention of fibrotic lesions In a preferred embodiment, drugs having heretofore unknown pharmacological properties which are useful in the medicinal therapy of fibrotic disease for the reparation and prevention of fibrotic lesional tissues, such drugs including as the active ingredie... | 05/10/1994 |
| 5284835 | Use of dilinoleoylphosphatidylcholine (DLPC) for treatment and prevention of cirrhosis and fibrosis in the liver This invention encompasses pharmaceutical compositions and a dietary supplement for treating or preventing alcoholic cirrhosis of the liver which comprises administering about 1 to 3 grams per day of dilinoleoylphosphatidylcholine (DLPC).... | 02/08/1994 |
| 5208254 | Process for the preparation of zinc carbocysteinate compositions A process for the preparation of a zinc carbocysteinate composition useful in the treatment of hepatopathies, comprising the steps of combining a therapeutically effective amount of zinc carbocysteinate with appropriate vehicles or excipients, and wetting... | 05/04/1993 |
| 5196437 | Method for treating hepatic diseases and regenerating liver tissue using FK 506 and related compounds Macrolide compounds having the structure shown below ##STR1## wherein R1 is hydroxy or protected hydroxy, R2 is hydrogen, hydroxy or protected hydroxy, R3 is methyl, ethyl, propyl or allyl, R4 is hydroxy, m... | 03/23/1993 |
| 5162361 | Method of treating diseases associated with elevated levels of interleukin 1 The present invention relates to a method of treating diseases associated with elevated levels of interleukin 1 (IL-1) including inflammatory diseases such as arthritis, skin hypersensitivity and endotoxemia. More specifically, the invention relates to a ... | 11/10/1992 |
| 5112827 | Drug to reverse fatty liver and atheromatous lesions The present invention comprises an amazingly effective method for the treatment, prevention and reversal of diet-induced high fat or alcohol-induced tissue-degernative conditions. More specifically, the present invention involves the discovery that pentox... | 05/12/1992 |
| 5102910 | Pharmaceutical preparation and method of treatment for liver dysfunction A pharmaceutical composition for the treatment of a liver disorder, comprising as an effective agent against liver dysfunction, a mixture in effective amounts of the components: (a) L-Asparaginic acid; (b) L-Cysteine; (c) L-Glutaminic acid; (d) sodium selenate... | 04/07/1992 |
| 5096920 | 1,2-dithiol-3-thion-S-oxide compounds and pharmaceutical compositions The use of 5-phenyl-3H-1,2-dithiol-3-thion-S-oxides which are optionally substituted in the phenyl ring as active substances in hepato-protective medicaments and new 5-phenyl-3H-1,2-dithiol-3-thion-S-oxides which are substituted in the phenyl ring are des... | 03/17/1992 |
| 4790991 | Ingestible aggregate and delivery system prepared therefrom The present invention relates to an ingestible aggregate comprising a pre-swelled substantially anhydrous hydrocolloid and a substrate. More particularly this invention relates to an aggregate having as a substrate a dietary fiber and/or drug wherein the ... | 12/13/1988 |
| 4678807 | Method for directed visceral metabolism of medium chain triglycerides Method for providing caloric nutrition via liquid emulsions, to a patient with dysfunctional visceral organ comprising parenterally administering to the patient a lipid emulsion containing from about 10% to 50% by weight of long chain triglycerides and th... | 07/07/1987 |
| 4080442 | Disaccharide derivatives used in the treatment of hepatic diseases A pharmaceutical composition containing as its active ingredient a disaccharide derivative having a derivative group of the following formula (1) bonded to a carbon atom of a disaccharide: ##STR1## wherein Y is a member of the group consisting of NH ... | 03/21/1978 |
| 3961064 | Pharmaceutical composition for remedy of hyperammoniemia Warm-blooded animals having hyperammoniemia are treating by administration of a pharmaceutical composition comprising nicotinohydroxamic acid.... | 06/01/1976 |
| 3947479 | Reduction of serum lipid levels, and agents and compositions useful therefor A method for lowering elevated serum lipid concentrations comprising administering a composition containing, as the active ingredient, a 3ଲ -substituted-16-cyanopreg-5-en-20-one wherein the substituent at the 3ଲ-position is selected fro... | 03/30/1976 |
